Screening patients at risk for diabetic foot ulceration: A comparison between measurement of vibration perception threshold and 10-g monofilament test

International Wound Journal

Volumn 11, Issue 2, 2014, Pages 147-151

  Richard, Jean Louis ^a   Reilhes, Lise ^a   Buvry, Stéphanie ^a   Goletto, Monique ^a   Faillie, Jean Luc ^b  

^a Centre Medical   (France)

^b DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Foot ulcer; Monofilament; Screening; Vibration perception threshold

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC FOOT; DIABETIC PATIENT; DIAGNOSTIC EQUIPMENT; DISEASE DURATION; FEMALE; FOOT; HALLUX; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTIVE THRESHOLD; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING; SENSATION; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; VIBRATION SENSE; YOUNG ADULT; DIABETIC NEUROPATHIES; MASS SCREENING; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; VIBRATION;

ADULT; AGED; AGED, 80 AND OVER; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSORY THRESHOLDS; VIBRATION; YOUNG ADULT;

EID: 84897073976     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2012.01051.x     Document Type: Article

References (36)

1. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005 ; 293: 217 - 28.
2. Crawford F, Inkster M, Kleijnen J, Fahey T. Predicting foot ulcers in patients with diabetes: a systematic review and meta-analysis. Q J Med 2007 ; 100: 65 - 86.
3. Armstrong DG, Lavery LA, Vela SA, Quedebeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med 1998 ; 158: 289 - 92.
4. Boulton AJW, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, Lavery LA, LeMaster JW, Mills JL, Mueller MJ, Sheehan P, Weekish DK. Comprehensive foot examination and risk assessment. A report of the task force of the foot care interest group of the American diabetes association, with endorsement by the American association of clinical endocrinologists. Diabetes Care 2008 ; 31: 1679 - 85.
5. Sosenko JM, Kato M, Soto R, Bild DE. Comparison of quantitative sensory-threshold measures for their association with foot ulceration in diabetic patients. Diabetes Care 1993 ; 13: 1057 - 61.
6. Liniger C, Albeanu A, Moody JF, Richez J, Bloise D, Assal JP. The thermocross: a simple tool for rapid assessment of thermal sensation thresholds. Diabetes Res Clin Pract 1991 ; 12: 25 - 34.
7. Vileikyte L, Hutchings G, Hollis S, Boulton AJM. The tactile circumferential discriminator. A new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care 1997 ; 20: 623 - 6.
8. Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J Fam Pract 2000 ; 49 Suppl: S17 - 29.
9. Kumar S, Fernando DJS, Veves A, Knowles EA, Young MJ, Boulton AJM. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract 1991 ; 13: 63 - 8.
10. Garrow AP, Boulton AJM. Vibration perception threshold - a valuable assessment of neural dysfunction in people with diabetes. Diabetes Metab Res Rev 2006 ; 22: 411 - 9.
11. Perkins BA, Orszag A, Ngo M, Ng E, New P, Bril V. Prediction of incident diabetic neuropathy using the monofilament examination. Diabetes Care 2010 ; 33: 1549 - 54.
12. Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care 1998 ; 21: 1714 - 9.
13. Jayaprakash P, Bhansali A, Bhansali S, Dutta P, Anantharaman R, Shanmugasundar G, Ravikiran M. Validation of bedside methods in evaluation of diabetic peripheral neuropathy. Indian J Med Res 2011 ; 133: 645 - 9.
14. Miranda-Palma B, Sosenko JM, Bowker JH, Mizel MS, Boulton AJM. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diabetes Res Clin Pract 2005 ; 70: 8 - 12.
15. Apelqvist J, Bakker K, van Houtum WH, Schaper NC, on behalf of the International Working Group on the Diabetic Foot (IWGDF) Editorial Board. Practical guidelines on the management and prevention of the diabetic foot. Diabetes Metab Res Rev 2008 ; 24 Suppl 1: S181 - 7.
16. Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diabetes Care 2000 ; 23: 984 - 8.
17. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1999 ; 17: 557 - 60.
18. Bland JM, Altman DG. Statistical method for assessing agreement between two methods of clinical measurement. Lancet 1986 ; 327: 307 - 10.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977 ; 33: 159 - 74.
20. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration. A prospective multicenter trial. Diabetes Care 2000 ; 23: 606 - 11.
21. Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract 2001 ; 54: 115 - 28.
22. Kärvestedt L, Mårtensson E, Grill V, Elofsson S, von Wendt G, Hamsten A, Brismar K. The prevalence of peripheral neuropathy in a population-based study of patients with type 2 diabetes in Sweden. J Diabetes Complicat 2011 ; 25: 97 - 106.
23. Paisley AN, Abbott CA, van Schie CHM, Boulton AJM. A comparison of Neuropen against standard quantitative sensory-threshold measures for assessing nerve function. Diabet Med 2002 ; 19: 400 - 5.
24. Gin H, Rigalleau V, Baillet L, Rabemanantsoa C. Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication. Diabetes Metab 2002 ; 28: 457 - 61.
25. Feng Y, Schlösser FJ, Sumpio BE. The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. J Vasc Surg 2009 ; 50: 675 - 82.
26. McGill M, Molyneaux L, Spencer R, Heng LF, Yue DK. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care 1999 ; 22: 598 - 602.
27. Werner MU, Rotbøll-Nielsen P, Ellehuus-Hilmersson C. Humidity affects the performance of von Frey monofilaments. Acta Anaesthesiol Scand 2011 ; 55: 577 - 82.
28. Tan LS. The clinical use of the 10 g monofilament and its limitations: a review. Diabetes Res Clin Pract 2010 ; 90: 1 - 7.
29. Bril V, Kojic J, Ngo M, Clark C. Comparison of a neurothesiometer and vibration in measuring vibration perception thresholds and relationship to nerve conduction studies. Diabetes Care 1997 ; 20: 1360 - 2.
30. Bril V, Perkins BA. Comparison of vibration perception thresholds obtained with the neurothesiometer and the CASE IV and relationship to nerve conduction studies. Diabet Med 2002 ; 19: 661 - 6.
31. Wiles PG, Pearce SM, Rice PJS, Mitchell JMO. Vibration perception threshold: influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabet Med 1991 ; 8: 157 - 61.
32. Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetric neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care 1994 ; 10: 1172 - 7.
33. Shearer A, Scuffham P, Gordois A, Oglesby A. Predicted costs and outcomes from reduced vibration detection in people with diabetes in the U.S. Diabetes Care 2003 ; 26: 2305 - 10.
34. Mc Gill M, Molyneaux L, Yue DK. Which diabetic patients should receive podiatry care? An objective analysis. Int J Med 2005 ; 35: 451 - 6.
35. Rayman G, Vas PR, Baker N, Taylor CG, Gooday C, Alder AI, Donohoe M. The Ipswich Touch Test. A simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care 2011 ; 34: 1517 - 8.
36. Bracewell N, Game F, Jeffcoate W, Scammell BE. Clinical evaluation of the VibraTip: a new device in the assessment of peripheral sensory neuropathy in diabetes. Diabet Med 2012. DOI: 10.1111/j.1464-5491.2012.03729.x. [Epub ahead of print].